Speaking Engagements
Connecting the Dots: From Custodian Interview to the Review Platform
December 11, 2025 | 12:00 PM – 1:00 PM ET
Debbie Spranger and Andrew Zappia, partners with Troutman Pepper, were quoted in the November 11, 2024 The Legal Intelligencer article, “Life Sciences M&A Set to Boom, Litigation to Remain Steady Under New Trump Admin.”
“M&A has been down in 2024. That’s not a secret. But I’m already receiving phone calls from companies looking to get back into the M&A market in a big way now that the elections results have been announced,” said Troutman Pepper Hamilton & Sanders health care and life sciences co-chair Deborah Spranger. “I got a call from a client looking to not only increase the volume of their M&A work but also increase the size of the deals they’re doing. … The demand for transactional work at firms across the country is going to increase significantly in 2025.”
…
“We see a fairly consistent amount of litigation in the pharmaceutical space and … the election result isn’t going to drive change one way or the other,” said Troutman Pepper health sciences intellectual property leader Andrew Zappia. “The one thing that is pretty constant in the legal business is that changes in the regulatory environment, either way, usually leads to more work for lawyers. Changes in whatever political direction usually mean that clients have to react and need assistance.”
Insight Industries + Practices
This just in
Firm Events
Artificial Intelligence Legal Update: Bringing Order to the Chaos
December 10, 2025 | 12:00 PM – 1:00 PM ET
ON24
Speaking Engagements
Navigating the Current Distressed CMBS Market: Strategies for Lenders; Opportunities and Challenges
December 9, 2025 | 1:00 PM – 2:30 PM ET
Webinar
Speaking Engagements
CompensationStandards.com Webcast – Equity Award Approvals: From Governance to Disclosure
December 3, 2025 | 2:00 PM – 3:00 PM ET
Virtual